Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- North Chesterfield, Virginia
- Most recent report
- 8-K, filed Oct 15, 2026
- Incorporated
- Delaware
- Filings on record
- 549 filings
- On EDGAR
- CIK 1625297
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 345
News 8 of 37
- 8-K Shareholder vote results Oct 15, 2026
- 8-K Other events Oct 6, 2026
- 8-K Other events Sep 17, 2026
- 8-K Current report on a material event Sep 15, 2026
- 8-K Current report on a material event Aug 3, 2026
- 8-K Quarterly results Aug 3, 2026
- 8-K Significant contract Aug 3, 2026
- 8-K Leadership change May 15, 2026
Prospectuses and Registrations 8 of 9
- 424B3 Prospectus supplement for an offering Sep 11, 2026
- S-4/A Registration statement for a merger or exchange, amended Sep 9, 2026
- S-4 Registration statement for a merger or exchange Aug 28, 2026
- S-8 Registration statement for an employee plan Jan 26, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jan 26, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jan 26, 2026
- S-8 POS Post-effective amendment to an employee plan registration Oct 24, 2024
- S-8 Registration statement for an employee plan Oct 24, 2024
Proxies 2
Ownership 8 of 113
- SCHEDULE 13G Large holder reported a passive stake Sep 30, 2026
- 4 Insider reported a trade Aug 27, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 13, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Jul 13, 2026
- 144 Notice of a proposed sale of restricted stock Jul 10, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 43
Everything here comes from Indivior Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.